Dr. Michael Dobryansky, MD

Dr. Dobryansky practices at Long Island Plastic Surgical Group in Babylon, New York.

Dr. Dobryansky's NPI, 1073636908, was assigned on April 7, 2007. Dr. Dobryansky graduated from New York University School of Medicine in 1999. Dr. Dobryansky holds New York license 227532.

Dr. Dobryansky's primary practice is Long Island Plastic Surgical Group, at 200 W Main St, Babylon, NY 11702 in Suffolk County. The practice phone is (516) 742-3404.

Dr. Dobryansky's primary practice is Long Island Plastic Surgical Group in Babylon, New York. Dr. Dobryansky is also affiliated with Tisch Hospital. The medical group on file is New York Plastic Surgical Group. Dmand AI also links Dr. Dobryansky to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dobryansky practices, 6 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Dobryansky's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Dobryansky is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Dobryansky's licenses on file in 4 states: New York, Delaware, New Jersey and Ohio.

Dmand AI lists breast surgery, chronic skin ulcer, head wound and removal of damaged skin or skin graft among the conditions Dr. Dobryansky treats.

CMS data shows 271 Medicare services from Dr. Dobryansky across 3 procedure codes in 2024, for 151 Medicare patients. Medicare paid $170,816 for them.

CMS counts 151 Medicare patients who saw Dr. Dobryansky in 2024. The largest group is 65 to 74, with 67 patients. 75% of them have arthritis, and 75% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dobryansky's median patient age at 52, with 61% women.

In 2024, Dr. Dobryansky wrote 31 Medicare Part D claims for 20 patients. 84% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $6,262 in total drug cost. In 2021, CMS named 13 claims across 1 drug.

Dr. Dobryansky accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 15 papers to Dr. Dobryansky in 2015. The most frequent topics are Ischemia, Mandible and Plastic Surgery Procedures. Dr. Dobryansky has published most often in Ann Plast Surg. Dr. Dobryansky's most frequent co-authors are Russell Lee Ashinoff, MD, Kirit Bhatt, MD and Noel Blythe Natoli, MD.

CMS Open Payments shows 144 general payments to Dr. Dobryansky from 25 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 53% of the total. Merz North America, Inc. paid the most, $18,384. It also lists 4 research payments totaling $10,825 from 2022 to 2023.

Dmand AI lists 1 award for Dr. Dobryansky.

Dr. Dobryansky graduated from New York University School of Medicine in 1999. Dr. Dobryansky is a member of ACS and ASPS.

Dr. Dobryansky is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.